A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells
Biomaterials Science · 2025
DOI: 10.1039/d4bm01471e ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2025. Verfasst von Jiahao Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Third Xiangya Hospital of Central South University, No. 138, Tongzipo Road, Changsha, 410013, Hunan, China. 602536@csu.edu…. Hauptthemen laut MEDLINE: Epithelial Cell Adhesion Molecule, Urinary Bladder Neoplasms, Aptamers, Nucleotide, Deoxycytidine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Basic Research Program of China, Natural Science Foundation of Hunan Province, Central South University.
Abstract (Originalsprache)
Schematic diagram of the synthesis of EpCAM-GEMs and their role in cells (bladder cancer cells and bladder cancer stem cells).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, The Third Xiangya Hospital of Central South University, No. 138, Tongzipo Road, Changsha, 410013, Hunan, China. 602536@csu.edu.cn.
- Chongqing Key Laboratory for Pharmaceutical Metabolism Research, College of Pharmacy, Chongqing Medical University, No. 1, Yixueyuan Road, Chongqing, 400016, China.
- School of Medicine, Hunan University of Chinese Medicine, Grade 2024, China.
- Institute of Chinese Materia Medica, Hunan Academy of Chinese Medicine, No. 8, Yuehua Road, Changsha 410013, China.
- Department of Urology, Sun Yat-sen University Cancer Center, No. 651, Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
- State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, No. 651, Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
Förderung
- National Basic Research Program of China
- Natural Science Foundation of Hunan Province
- Central South University
Zitieren
APA
Liu, J., Wang, L., Peng, Y., Long, S., Zeng, H., Deng, M., Xiang, W., Liu, B., Hu, X., Liu, X., Xie, J., Hou, W., Tang, J., & Liu, J. (2025). A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells. Biomaterials Science. https://doi.org/10.1039/d4bm01471e
Vancouver
Liu J, Wang L, Peng Y, Long S, Zeng H, Deng M, et al. A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells. Biomaterials Science. 2025. doi:10.1039/d4bm01471e
BibTeX
@article{Liu2025,
author = {Liu, Jiahao and Wang, Long and Peng, Yongbo and Long, Shuyang and Zeng, Hongliang and Deng, Minhua and Xiang, Wei and Liu, Biao and Hu, Xing and Liu, Xuewen and Xie, Jianfei and Hou, Weibin and Tang, Jin and Liu, Jianye},
title = {A novel therapeutic strategy utilizing EpCAM aptamer-conjugated gemcitabine for targeting bladder cancer and cancer stem cells},
journal = {Biomaterials Science},
year = {2025},
doi = {10.1039/d4bm01471e}
}
EUVIMED